Johnson & Johnson New Covid-19 Vaccine

Johnson & Johnson has just received approval from the FDA for emergency use of their COVID-19 vaccine, making it the 3rd vaccine, and the first typical “viral vector” vaccine to treat COVID here in the United States. Johnson & Johnson joins Astrazeneca as a more traditional alternative to the Moderna and Pfizer mRNA vaccines approved for COVID. Traditional vaccines inject actual pieces of a virus, whether alive or dead, to elicit a response from our …